Introduction. Platelet function, platelet volume indices, traditional markers of lipid me tabolism, inflammatory markers and a novel biomarker, cyclophilin A (CyPA), are related as far as they have implications in pathogenesis of atherosclerosis. The purpose of this study was to evaluate interrelations among these factors, correlation between platelet function and inflammatory factors, also a function of CyPA.
INTRODUCTION
Atherosclerosis is a chronic inflammatory disease that plagues humankind for millennia. Carl von Rokitansky and Rudolf Virchow controversially explained the concept of inflammatory causes in the middle of the 19th century (1) . Since then importance of inflammation in the development of cardiovascular diseases (CVD) has been widely studied. At present, it is clear that inflammation plays a key role in pathogenesis of atherosclerosis and it is not anymore just a cholesterol storage disease characterized by the collection of cholesterol and thrombotic debris in the artery wall (2) . It involves both innate and adaptive immune mechanisms. Direct factors affecting the process include lipid deposition and oxidation, accumulation of cell-derived microparticles and various non-lipid lipoprotein associated factors. Indirectly inflammation at non-vascular sites can also contribute to progression of atherosclerosis (i. e. autoimmune diseases, smoking, respiratory infections and pollution exposure) (3) .
The well-known atherosclerotic cardiovascular disease risk factors (decreased high-density lipoprotein cholesterol (HDL-C) and increased low-density lipoprotein cholesterol (LDL-C) concentrations in blood) are not enough for complete risk evaluation (4) and creation of treatment strategies in clinical practice (5) . For these purposes, other multiple markers have been established as risk factors. For example, C-reactive protein (CRP) is greatly used as an independent predictor of cardiovascular diseases due to discovery of high-sensitivity techniques for its determination, stable concentrations in blood and relatively low testing costs (6) (7) (8) . Similarly, the von Willebrand factor (vWF) (9) (10) (11) and fibrinogen (12) , given their key roles in arterial thrombus formation, as biomarkers attract considerable interest in predicting CVD. Platelets, previously known only for their clear role in hemostasis, now increasingly gain interest as inflammatory cells contributing to pathophysiology of CVD (13) (14) (15) . One of the contribution theories states platelet hyperreactivity, which manifests as increased aggregability, alterations in platelet volume indices (increased mean platelet volume (MPV), increased platelet distribution width (PDW) and increased platelet large cell ratio (P-LCR) independently of combination of changes) (16) (17) (18) (19) (20) , increased expression of P-selectin (21) and other molecules, also active counteraction between monocytes and other leucocyte populations (22, 23) .
One of the novel biomarkers of CVD is cyclophilin A (CyPA). Normally an intracellular protein, CyPA, is secreted from monocytes / macrophages, endothelial cells, vascular smooth muscle cells and platelets in response to reactive oxygen species. Linkage between CyPA and cardiovascular events has been described in several studies, where increased concentrations of the protein were regarded as a risk factor to acute coronary syndromes (24) (25) (26) (27) .
Platelet function, platelet volume indices, traditional markers of lipid metabolism (total cholesterol (TC), LDL-C, HDL-C, triglycerides (TG)), inflammatory markers (CRP, vWF and fibrinogen) and CyPA, a novel biomarker, are all related as having implications in the pathogenesis of atherosclerosis. The purpose of the study was to evaluate relations among these factors, a correlation between the platelet function and inflammatory factors, also the function of CyPA.
MATERIALS AND METHODS
160 male patients (age mean 47.79 ± 4.01 years) with high risk of atherosclerosis and metabolic syndrome were included in the study. Inclusion criteria were represented by the presence of cardiovascular risk factors: disturbances in lipids profile (high TC and / or high LDL-C and / or low HDL-C), increased weight, smoking, acute or chronic stress, no previous or current acute cardiovascular illness, and high risk of diseases and presence of stress confirmed by a physician. The study was approved by the Vilnius Regional Biomedical Research Ethics Committee and followed the Declaration of Helsinki. All participants provided a written informed consent before inclusion into the study.
Laboratory analysis was performed in the Center of Laboratory Medicine of Vilnius University Hospital Santariškių Clinics. The list of performed routine and specific tests, methods (and / or used analyzers) and baseline characteristics of the studied population are summarized in Table 1 . All laboratory tests were performed the same day when blood was drawn, except vWF and CyPA. Citrated plasma was kept frozen at -20 °C and vWF was analyzed in several batches. Serum was kept frozen at -70 °C and CyPA was performed in several batches. Due to zero CyPA µg/ mL values (76 of 160) additional units for this parameter were calculated (signal to cut-off ratio, s/co).
Biochemical metabolic syndrome basis was confirmed as present (n = 23, 14.4 %) if all three bio chemical criteria (TG ≥ 1.7 mmol/l, HDL-C <1.03 mmol/l and glucose >5.6 mmol/l) were met. Different lipid ratios (TG/HDL-C, atherogenic index -lg[TG/HDL-C], TC/HDL-C and LDL-C/ HDL-C) and lipid-CRP ratios (LDL-C/CRP, CRP/ LDL-C, TC/CRP, CRP/TC, HDL-C/CRP, CRP/ HDL-C and lg[CRP/HDL-C]) were calculated. Lipid-CRP ratios were evaluated as absolute numbers without estimated units of measure.
In order to evaluate the prognostic value of lipid ratios or lipid-CRP ratios, we have used cutoffs of each ratio. Cut-offs were calculated in our another unpublished study where patients with acute myocardial infarction were involved. Cutoffs for lipid ratios and lipid-CRP ratios where CRP was used as a denominator were calculated as means of values obtained from individuals with risk factors and individuals with diagnosed CVD. Lipid-CRP ratios where CRP was used as a numerator cut-offs were calculated as means and one standard deviation of values obtained from individuals with risk factors.
Statistical analysis was performed using the SPSS software (PASW Statistics 18 version, SPSS Inc., USA). Continuous variables were expressed as means and standard deviations (SD). Data comparison was made by the Student t-test, ANO-VA or Mann-Whitney U test where appropriate. Categorical variables were presented as frequencies and percentages and were compared by the chi-square test. The Spearman coefficient (r) was calculated to quantify the correlation between variables. Correlation was considered weak when the r value was below 0.3, moderate when the value was between 0.3 and 0.7, and strong when the value was above 0.7. Diagnostic characteristics of the markers were evaluated by ROC curves. The markers were considered as useful if the area under the ROC curve (AUC) was >0.5. Linear regression models were considered applicable if the coefficient of determination r 2 was ≥0.25. All reported p values were two tailed and a p value of <0.05 was considered as statistically significant.
Results
Baseline characteristics of the study population (n = 160) are presented as means ±SD in Table 1 . Parameters were evaluated according to the approved reference values at the Center of Laboratory Medicine. Frequencies of abnormal results, reference values and estimated abnormality are summarized in Table 2 . CRP values were divided into four groups: only the results <1.0 mg/L were considered normal with low risk of CVD events. Each variable deviation from the reference range was considered as a separate risk factor, and analyzed according to the total number of risk factors In the analysis of the whole investigated population (n = 160) correlations of lipids (TC, TG, HDL-C and LDL-C) were as expected: TC correlation with other lipids was moderate to strong and significance level was high (p ≤ 0.009); HDL-C significant negative correlation was noted with TG (r = -0.333; p < 0.001).
Statistically significant interrelatedness of inflammatory factors was noted: vWF correlated positively with fibrinogen (r = 0.229; p = 0.004) and CRP (r = 0.224; p = 0.004), whereas the CRP correlation with fibrinogen (r = 0.471; p < 0.001) was moderate and positive (Fig. 3) . The negative correlation of MPV with CD42a/ CD14 percentage (r = -0.281; p < 0.001), CD42a/ CD14 events number (r = -0.327; p < 0.001) and CD14 number (r = -0.198; p < 0.012) was registered. Similar statistically significant correlations were seen for PDW and P-LCR, except their negative correlations with CD14 number (PDW r = -0.240, p = 0.002 and P-LCR r = -0.209, p = 0.008, respectively). MPV correlations with CD42a/CD14 and CD42a are depicted in Fig. 5 . According to significant correlations, linear regression models were adapted for each laboratory risk factor. Successful models of different independent markers are shown in Tables 3 and 4 . Fibrinogen concentration depended on the combination of three variables, i. e. vWF, PLT and Pct (one of those but not together), and CRP or one of lipid-CRP ratios (when CRP is positioned in a fraction as a numerator). Two examples of the latter are shown in Table 4 . Despite statistically significant TRAP correlations with vWF, CRP, PLT, Pct, MPV, P-LCR, CD42a (in two different combinations) and lipid-CRP ratios, there were no successful linear regression models for TRAP. The univariate regression analysis revealed that the prognostic marker for vWF is fibrinogen but not CRP. The CRP linear regression model with fibrinogen shows reli able dependency of these analytes (F 41.880, constant -5.782, p < 0.001), although r 2 = 0.210 is somewhat lower than the established criterion (Fig. 1) . Relations of glucose with CRP, CD42a/CD14%, CD42a (in combination with CD14) and TC/HDL-C ratio were reliable only when the constant factor was not used. There were no successful models of MPV with TRAP, PDW and P-LCR, but a significant link existed with flow cytometry parameters (Table 4) .
In the univariate regression analysis we have found that flow cytometry parameters of platelets can be predicted by established lipid ratios and lipid-CRP ratios cut-offs. Among other analytes high values of vWF and MPV were predictors of platelet activity (absolute numbers of CD42a, PAC-1 and CD63) and formation of platelet monocyte complexes (absolute numbers of CD42a/CD14). Results of the platelet function univariate analysis are presented in Tables 5 and  6 . The former table depicts prediction capabilities for platelet function parameters from the point of view of increased CVD risk (individuals having 5-7 laboratory risk factors), while the latter one from the point of view of increased MS risk (individuals with having 3 MS biochemical risk factors). Only absolute numbers of PAC-1/CD42a and CD42a (in combination with CD14) were According to the established cut-offs in Table 2 MS[+3] presence could be prognosticated by decreased HDL-C (cut-off < 0.91 mmol/L, odds ratio 3.41, 95% CI 1.37-8.53, Chi square 7.464, p = 0.009) and increased glucose concentrations (cut-off > 6.1 mmol/L, odds ratio 2.95, 95% CI 1.11-7.82, Chi square 5.023, p = 0.030), but not by deviations of fibrinogen, vWF, TRAP, TG, TC, LDL-C, CRP or MPV. The presence of 5-7 laboratory CVD risk factors could be prognosticated by the most analysed factors (Table 7) . Considering that CRP values below 1.0 mg/L are associated with low CVD risk, CRP values corresponding to high CVD risk may influence increment of MPV values (>10.4 fL) with an odds ratio of 2.46 (95% CI 1.00-6.05, Chi square 4.017, p = 0.050) and vice versa -high MPV values are associated with increased CRP values. Higher concentrations of fibrinogen (>4 g/L) may be determined by increased TRAP aggregability (>150 U) (odds ratio 5.27, 95% CI 1.57-17.67, Chi square 8.576, p = 0.007). Likewise higher TG concentrations (>1.8 mmol/l) may be detected 5.12 times more often when the acute stress fact is concerned (95% CI 1.37-19.14, Chi square 6.731, p = 0.015).
DISCUSSION
The purpose of the study was to evaluate three aspects of the investigated markers' associations in men having increased risk of CVD (especially with alterations in lipids profile): first, behaviour of platelets (possibility of hyperreactivity), second, activity of inflammatory markers, and third, association of inflammation with platelet function.
Platelets role in the pathogenesis of atherosclerosis can be described by platelet increased reactivity markers: number, size, tendency to form aggregates and concentrations of released substances from granules (28) . We have studied actual numbers of platelets, their indices reflecting size variations (especially MPV and P-LCR). Platelet function was analysed by flow cytometry (expression of CD42a for Glycoprotein IX; expression of CD63 for an integral protein of platelet dense granule and lysosomal membranes; PAC-1 binding capacity for GP IIb/IIIa in activated platelets; and expression of CD14 for monocytes). Additionally, aggregability was assessed with TRAP agonist and concentrations of vWF and fibrinogen were measured. Platelet count and MPV may change independently, and our results show an inverse correlation, which is the most common combination of results (16) . Despite this, PLT and MPV can be separately associated with increased platelet reactivity and also with increased risk of coronary syndromes We next focused on inflammatory markers: CRP, fibrinogen and vWF. Each of these is separately known as a risk factor for CVD (6) (7) (8) (9) (10) (11) (12) . A meta-analysis of published data from 18 studies, involving about 4 000 CVD cases, indicated a relative risk of 1.8 (95% CI 1.6-2.0) per 1 g/L increase in plasma fibrinogen level (12) . For vWF data is ambiguous: not all authors succeeded in showing a positive relationship between vWF levels and CVD events (29, 30) . It has been demonstrated that high CRP levels can predict risk of myocardial infarction, stroke or cardiac death in apparently healthy subjects. At the same time, presence of metabolic syndrome correlates with high levels of CRP. The most important aspect of this biomarker is that it has an independent predictive potential if high-sensitivity assay (hs-CRP) is used. Thus, cardiovascular risk may be categorized depending on the level of CRP (31). In our results, we have shown interrelatedness of CRP, fibrinogen and vWF values. In most cases, vWF was seen as a predictor of platelet functions. CRB was associated with platelets only indirectly by using lipid-CRP ratios.
Additionally, a statistically significant positive correlation was observed for CyPA in different risk categories according to CRP levels. Although linearity was not perfect, CyPA results correspond to the theory of protein's involvement in inflammatory processes (24, 26) . A relationship between CyPA and CD42a/CD14 expression was found, which might indicate that monocytes and / or platelet-monocyte complexes, but not platelets, are responsible for increased CyPA levels in blood. Furthermore, CD42a/ CD14 expression related to TC and LDL-C might indicate that monocytes and / or platelet-monocyte complexes play an important role in the development of atherosclerosis.
CONCLUSIONS
The present study suggests that platelets in men with dyslipidemia and other risk factors have a tendency to be hyperreactive and this fact might be considered as a separate risk factor for CVD. Inflammatory status of individuals having risk factors of CVD does not correlate with the platelet function. According to our results CyPA reflects inflammatory processes but not the platelet function. 
Santrauka
Įvadas. Trombocitų funkcija, jų tūrio indeksai, tradiciniai lipidų apykaitos žymenys, uždegimo žymenys ir naujasis žymuo ciklofilinas A (CyPA) yra tarpusavyje susiję, nes dalyvauja aterosklerozės patogenezėje. Šio tyrimo tikslas -įvertinti galimus minėtų veiksnių ryšius, nustatyti sąsajas tarp trombocitų funkcijų ir uždegimi-nių žymenų, taip pat CyPA funkciją. Tiriamieji ir metodika. Į tyrimą įtraukta 160 vyriš-kos lyties asmenų, turinčių išreikštų aterosklerozės ir metabolinio sindromo (MS) rizikos veiksnių. Kriterijai: lipidų apykaitos žymenų pakitimai, antsvoris, rūkymas, ūminis arba lėtinis stresas, ūminės širdies ir kraujagyslių ligos nebuvimas ir kiti rizikos veiksniai, patvirtinti gydytojo. Atlikti C-reaktyviojo baltymo (CRB), Vilebrando faktoriaus (vWF), fibrinogeno, CyPA tyrimai. Trombocitų funkcija įvertinta agregacijos ir tėkmės citometrijos metodais.
Rezultatai. Didėjant rizikos veiksnių skaičiui statistiškai patikimai didėjo fibrinogeno, agregacijos su trombino receptorius aktyvinančiu peptidu (TRAP), triacilglicerolių, bendrojo cholesterolio, mažo tankio lipoproteinų cholesterolio, CRB, gliukozės, vidutinio trombocitų tūrio (MPV), trombocitų didelių ląstelių santykio (P-LCR) ir kai kurių lipidų santykių vertės, o tiesiškumo reikšmingumo lygmuo buvo labai didelis (p ≤ 0,004). MPV koreliacija su CD42a buvo teigiama (r = 0,605; p < 0,001), o su CD42a/CD14 -neigiama (r = -0,327; p < 0,001). Nustatyta, jog lipidų santykiai -biocheminių MS žymenų prognostiniai požymiai. Trombocitų funkcijų parametrai buvo susiję su lipidų santykiais, lipidų-CRB santykiais, MPV ir vWF. Nustatyta CyPA koreliacija su CD42a/CD14 (r = 0,202, p = 0,010).
Išvados. Vyrų su dislipidemija ir kitais rizikos veiksniais trombocitai turi polinkį į padidėjusį reaktyvumą. Tai gali būti vertinama kaip atskiras širdies ir kraujagyslių ligų rizikos veiksnys. Uždegiminė būklė nekoreliuoja su trombocitų funkcija. CyPA atspindi uždegiminius procesus, o ne trombocitų funkciją.
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